AVROBIO announces merger with Tectonic Therapeutic in significant all-stock deal
AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc., a biotechnology firm specializing in GPCR (G-protein coupled receptor)-targeted therapeutic proteins, have announced a definitive merger agreement. ... Read More
Avrobio gets FDA orphan status for AVR-RD-02 in Gaucher disease
US gene therapy company Avrobio has secured orphan-drug designation for AVR-RD-02, its investigational gene therapy, for the treatment of Gaucher disease, from the US Food ... Read More